-+ 0.00%
-+ 0.00%
-+ 0.00%

*Cellectar Biosciences Aligns With FDA on Regulatory Path for Potential Accelerated Approval of Iopofosine I 131 for Waldenstrom macroglobulinemia

Dow Jones·03/13/2025 11:08:00

Please log in to view news